2026年11月4日星期三
M
विश्व व्यापक संदर्भ
वैश्विक ताज़ा ख़बरें
Ethics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaSingapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei AsiaThe great yen rebalancing— 日经 Nikkei AsiaNintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei AsiaNorth Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei AsiaJapan's IHI wins key role in Westinghouse's new Poland nuclear plant— 日经 Nikkei AsiaUS experts warm to Japanese nuclear subs as check on China in Asian waters— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaSingapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei AsiaThe great yen rebalancing— 日经 Nikkei AsiaNintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei AsiaNorth Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei AsiaJapan's IHI wins key role in Westinghouse's new Poland nuclear plant— 日经 Nikkei AsiaUS experts warm to Japanese nuclear subs as check on China in Asian waters— 日经 Nikkei Asia

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

स्रोत Nature 医学研究1 दिन पहले
सामग्री सारांश

यह साइट केवल शीर्षक और सारांश सूचकांक प्रदान करती है, पूरी सामग्री और कॉपीराइट मूल प्रकाशक के पास हैं, कृपया मूल लिंक पर क्लिक करके पढ़ें।

मूल पाठ पर जाएं
संबंधित चैनल
स्वास्थ्य
संबंधित क्षेत्र
वैश्विक दृष्टिकोण
मूल भाषा
English
प्रविष्टि संख्या
health-00a74bed

Comments 0 comments

No comments yet. Be the first.

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials · विश्व व्यापक संदर्भ